CIK 0001682852 · Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813467528
- Phone
- 6177146500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,875,818
- in 4 filings, $33.9M under 10b5-1 plans
Net −$33,875,818. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-04 | Mock James M Chief Financial Officer | Option exercise · Restricted Stock Units | −1,452 | 8,717 | ||
| 2025-03-07 | Klinger Shannon Thyme Chief Legal Officer | Option exercise | +1,139 | 26,163 | ||
| 2025-03-07 | Klinger Shannon Thyme Chief Legal Officer | Shares withheld for taxes | −551 | $34.30 | $19K | 25,612 |
| 2025-03-07 | Klinger Shannon Thyme Chief Legal Officer | Option exercise · Restricted Stock Units | −1,139 | 1,139 | ||
| 2025-03-03 | Bancel Stephane Chief Executive Officer | Purchase | +102,821 | $31.04 | $3.2M | 9,153,193 |
| 2025-03-03 | Bancel Stephane Chief Executive Officer | Purchase | +57,493 | $31.53 | $1.8M | 9,210,686 |
| 2025-03-03 | SAGAN PAUL Director | Purchase | +31,620 | $31.76 | $1.0M | 312,027 |
| 2025-03-01 | Mock James M Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +63,478 | 63,478 | ||
| 2025-03-01 | Mock James M Chief Financial Officer | Grant or award · Restricted Stock Units | +39,606 | 39,606 | ||
| 2025-03-01 | Klinger Shannon Thyme Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +55,543 | 55,543 | ||
| 2025-03-01 | Klinger Shannon Thyme Chief Legal Officer | Grant or award · Restricted Stock Units | +34,655 | 34,655 | ||
| 2025-03-01 | Hoge Stephen President | Grant or award · Stock Option (Right to Buy) | +238,043 | 238,043 | ||
| 2025-03-01 | Hoge Stephen President | Grant or award · Restricted Stock Units | +148,524 | 148,524 | ||
| 2025-03-01 | Bancel Stephane Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +357,065 | 357,065 | ||
| 2025-02-28 | Mock James M Chief Financial Officer | Option exercise | +329 | 15,034 | ||
| 2025-02-28 | Mock James M Chief Financial Officer | Shares withheld for taxes | −160 | $31.09 | $5K | 14,874 |
| 2025-02-28 | Mock James M Chief Financial Officer | Option exercise · Restricted Stock Units | −329 | 2,630 | ||
| 2025-02-28 | Klinger Shannon Thyme Chief Legal Officer | Option exercise | +233 | 24,968 | ||
| 2025-02-28 | Klinger Shannon Thyme Chief Legal Officer | Shares withheld for taxes | −113 | $31.09 | $4K | 24,855 |
| 2025-02-28 | Klinger Shannon Thyme Chief Legal Officer | Option exercise | +329 | 25,184 |
Page 18 of 20 · 389 trades